In normal aging, increased synaptic activity may drive PSA-NCAM upregulation, while in AD, chronic excitotoxicity, Aβ burden, and neuroinflammation likely accelerate its degradation or downregulate its synthesis. This evidence concerns the gene PROS1 and Alzheimer disease.